In this study we aimed to identify the frequency of different BCR-ABL transcripts in Syrian CML patients and highlight their significance on patient care in order to conclude a better approach to monitoring and treatment. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.